CNS vs CVBF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

CNS

66.5
AI Score
VS
CNS Wins

CVBF

58.9
AI Score

Investment Advisor Scores

CNS

67score
Recommendation
STRONG BUY

CVBF

59score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS CVBF Winner
Forward P/E 18.4502 11.534 CVBF
PEG Ratio 1.6881 1.4662 CVBF
Revenue Growth 11.1% 42.0% CVBF
Earnings Growth 0.0% -21.6% CNS
Tradestie Score 66.5/100 58.9/100 CNS
Profit Margin 28.2% 36.1% CVBF
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY CNS

Relative Price Performance (Last 90 Days)

CNS 1M: -4.5% · 3M: -11.4% CVBF 1M: +4.7% · 3M: +2.2%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $72.07

CVBF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $23.05

Fundamentals Snapshot

Metric CNS CVBF
Market Cap — —
Forward P/E 19.3 11.5
Trailing P/E 21.6 15.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.6%
EPS 3.25 1.43
Dividend Yield 0.04% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.